UPDATE: Heron Therapeutics Announces Results from Phase 3 MAGIC Study of SUSTOL: Says Primary Endpoint Achieved

By: via Benzinga
Heron Therapeutics, Inc. (NASDAQ: HRTX) today announced positive, top-line results from its recently completed Phase 3 MAGIC study. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.